N-MYC Amplification, Loss of Heterozygosity on the Short Arm of Chromosome 1 and DNA Ploidy in Retinoblastoma

European Journal of Cancer

Volumn 32, Issue 4, 1996, Pages 645-649

  Doz, F ^a   Peter, M ^a   Schleiermacher, G ^a   Vielh, P ^a   Validire, P ^a   Putterman, M ^b   Blanquet, V ^b   Desjardins, L ^a   Dufier, J L ^b   Zucker, J M ^a   Mosseri, V ^a   Thomas, G ^a   Magdelenat H ^a   Delattre, O ^b  

^a INSTITUT CURIE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

LOH 1p; Retinoblastoma; Risk factors; Tumorigenesis

Indexed keywords

ARTICLE; CHILD; CHROMOSOME 1P; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; ONCOGENE C MYB; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA;

CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; EYE NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, MYC; HETEROZYGOTE; HUMANS; INFANT; MALE; PLOIDIES; RETINOBLASTOMA;

EID: 0029932851     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00626-5     Document Type: Article

References (31)

1. Donaldson S, Egbert PR, Lee WH. Retinoblastoma. In Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology (2nd edition). Philadelphia, Lippincott, 1992, 683-696.
2. Shields CL, Shields JA, Baez KA, Cater J, De Potter P. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 1993, 77, 544-548.
3. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 1987, 94, 371-377.
4. Shields CL, Shields JA, Baez KA, Cater J, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994, 73, 692-698.
5. Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma: experience of a single institution in 33 patients. Cancer 1994, 74, 722-732.
6. Friend SH, Berbards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323, 643-646.
7. Dunn JM, Philips RA, Becker AJ, Gallie B. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science (Washington) 1988, 241, 1797-1800.
8. Xu HJ, Sumegi J, Hu SX, et al. Intraocular tumor formation of RB reconstituted retinoblastoma cells. Cancer Res 1991, 51, 4481-4485.
9. Cano J, Oliveros O, Yunis E. Phenotype variants, malignancy, and additional copies of 6p in retinoblastoma. Cancer Genet Cytogenet 1994, 76, 112-115.
10. Squire J, Philips RA, Boyce S, Godbout R, Rogers B, Gallie B. Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization. Hum Genet 1984, 66, 46-53.
11. Venkateswara RP, Helson L, Ellsworth RM, Reid T, Gilbert F. Chromosomal abnormalities in human retinoblastoma. A review. Cancer 1986, 58, 663-671.
12. Lee WE, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 1984, 307, 458-460.
13. Brodeur GM, Fong CT. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 1989, 41, 153-174.
14. Kyritsis AP, Tsokos M, Triche TJ, Chader GJ. Retinoblastoma - origin from a primitive neuroectodermal cell? Nature 1984, 307, 471-473.
15. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc oncogene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991, 9, 581-591.
16. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 1989, 86, 3753-3757.
17. Doz F, Neuenschwander S, Plantaz D, et al. Etoposide and carboplatin in extra-ocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 1995, 13, 902-909.
18. Sambrook J, Fritsch EF, Maniatis T. In Molecular Cloning. A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989.
19. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes, Chromosom Cancer 1994, 10, 275-281.
20. Peter M, Michon J, Vielh P, et al. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int J Cancer 1992, 52, 544-548.
21. Vielh P. Flow Cytometry. Guides to Clinical Aspiration Biopsy. New York, Igaku Shoin, 1991.
22. Shankey TV, Rabinovitch PS, Bagwell B, et al. Guidelines for the implementation of clinical DNA cytometry. DNA Cytometry Consensus Conference. Breast Cancer Res Treat 1993, 28, 61-68.
23. Chaum E, Ellsworth RM, Abramson DH, Haik BG, Kitchin FD, Chaganti RSK. Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification. Cytogenet Cell Genet 1984, 38, 82-91.
24. Kusnetsova LE, Prigogina EL, Pogosianz HE, Belkina BM. Similar chromosomal abnormalities in several retinoblastomas. Hum Genet 1982, 61, 201-204.
25. Squire J, Gallie B, Philips RA. A detailed analysis of chromosomal changes in heritable and non heritable retinoblastoma. Hum Genet 1985, 70, 291-301.
26. Bello MJ, Vaquero J, De Campos JM, et al. Molecular analysis of chromosome 1 abnormalities reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994, 57, 172-175.
27. Dracopoli NC, Harnett P, Bale SJ, et al. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 1989, 86, 4616-4618.
28. Zwaan CM, De Waal FC, Koole FD, et al. A giant congenital orbital tumor: an unusual presentation of retinoblastoma. Med Pediatr Oncol 1994, 23, 507-511.
29. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
30. Zerbini C, Gelber RD, Weinberg D, et al. Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 1993, 11, 616-622.
31. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC. Loss of heterozygosity for chromosomes 16q and 1p in Wilms tumors predicts an adverse outcome. Cancer Res 1994, 54, 2331-2333.